VIT-2763

· Vifor (International) Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIT-2763, covering 2023-12-14 to 2023-12-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia [Phase 2]

See pricing